Reductions in qEEG slowing over 1 year and after treatment with Cerebrolysin in patients with moderate-severe traumatic brain injury

Journal of Neural Transmission

Volumn 115, Issue 5, 2008, Pages 683-692

  Álvarez, X Antón ^a   Sampedro, Carolina ^a   Figueroa, Jesús ^a   Tellado, Iván ^a   González, Andrés ^a   García Fantini, Manuel ^b   Cacabelos, Ramón ^a   Muresanu, Dafin ^c   Moessler, Herbert ^d  

^a Centro de Investigacion Biomedica EuroEspes   (Spain)

^b HOSPITAL JUAN CANALEJO   (Spain)

^c IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^d Research Initiative Ebewe   (Austria)

Author keywords

Cerebrolysin; Cognitive performance; EEG power ratio; qEEG slowing; Quantitative EEG; Traumatic brain injury

Indexed keywords

CEREBROLYSIN; CITICOLINE; PIRACETAM;

ADULT; ARTICLE; ATTENTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; TRAUMATIC BRAIN INJURY; TREATMENT DURATION; WORKING MEMORY;

ADULT; AMINO ACIDS; BRAIN INJURIES; BRAIN MAPPING; COGNITION; ELECTROCARDIOGRAPHY; ELECTROENCEPHALOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEUROPROTECTIVE AGENTS; NEUROPSYCHOLOGICAL TESTS; TIME FACTORS;

EID: 44749084017     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-008-0024-9     Document Type: Article

References (56)

1. Akay F, Hiruma S, Sato T, Iwamoto N, Fujimoto M, Ioku M, Hasimoto S (1992) Neurotrophic factor-like effect of EPF1070 on septal cholinergic neurons after transections of fimbria-fornix in the rat brain. Histol Histopathol 7:213-221
2. Albrecht E, Hingel S, Crailsheim K, Windisch M (1993) The effects of cerebrolysin on survival and sprouting of neurons from cerebral hemispheres and from the brainstem of chick embryos in vitro. Adv Biosci 87:341-342
3. Álvarez XA, Fernández-Novoa L, Sanpedro C, Lombarda V, Windisch M, Cacabelos R (1999a) Neuroimmunotrophic effects of Cerebrolysin in an animal model of hipocampal degeneration induced by ß-Amyloid. In: Korczyn AD (ed) Vascular dementia. Monduzzi Editore, Bologna, pp 233-237
4. Álvarez XA, Mouzo R, Pichel V, Pérez P, Laredo M, Fernández-Novoa L, Corzo L, Zas R, Alcaraz M, Secades JJ, Lozano R, Cacabelos R (1999b) Double-blind placebo-controlled study with Citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion. Methods Find Exp Clin Pharmacol 21:633-644
5. Álvarez XA, Lombardi V, Corzo L, Pérez P, Pichel V, Laredo M, Hernández A, Freixeiro F, Sanpedro C, Lorenzo R, Alcaraz M, Windisch M, Cacabelos R (2000a) Oral Cerebrolysin enhances brain alpha activity and improves cognitive performance in elderly control subjects. J Neural Transm Suppl 59:315-328
6. Álvarez XA, Lombardi V, Fernández-Novoa L, García M, Sanpedro C, Cagiao A, Cacabelos C, Windisch M (2000b) Cerebrolysin reduces microglial activation in vivo and in vitro: a potential mechanism of neuroprotection. J Neural Transm Suppl 59:281-292
7. Alvarez XA, Sanpedro C, Perez P, Laredo M, Cruceiro V, Hernandez A, Figueroa J, Varela M, Arias D, Corzo L, Zas R, Lombardi V, Fernandez-Novoa L, Pichel V, Cacabelos R, Windisch M, Aleixandre M, Moessler H (2003) Positive effects of cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study. Int Clin Psychopharmacol 18:271-278
8. Álvarez XA, Cacabelos R, Laredo M, Couceiro V, Sampedro C, Varela M, Corzo L, Fernández-Novoa L, Vargas M, Aleixandre M, Illescas E, Linares C, Granizo E, Dafin M, Moessler H (2006) A 24-week, double-blind, placebo-controlled study of three dosages of Cerebrolysin in patients with mild to moderate Alzheimer's disease. Eur J Neurology 13:46-54
9. Angelakis E, Lubar JF, Stathopoulou S, Kounios J (2004) Peak alpha frequency: an electroencephalographic measure of cognitive preparedness. Clin Neurophysiol 115:887-897
10. Axelrod BN, Fichtenberg NL, Liethen PC, Czarnota MA, Stucky K (2001) Performance characteristics of postacute traumatic brain injury patients on the WAIS-III and WMS-III. Clin Neuropsychol 15:516-520
11. Bae CY, Cho CY, Cho K, Hoon Oh B, Choi KG, Lee HS, Jung SP, Kim DH, Lee S, Choi GD, Cho H, Lee H (2000) A double-blind, placebo-controlled, multicenter study of Cerebrolysin for Alzheimer's disease. J Am Geriatr Soc 48:1566-1571
12. Berger RP, Pierce MC, Wisniewski SR, Adelson PD, Kochanek PM (2002) Serum S100B concentrations are increased after closed head injury in children: a preliminary study. J Neurotrauma 19:1405-1409
13. Boado R, Dafang W, Windisch M (1999) In vivo upregulation of the blood-brain barrier GLUT-1 glucose transporter by brain-derived peptides. Neurosci Res 34:217-224
14. Boly M, Faymonville ME, Peigneux P, Lambermont B, Damas P, Del Fiore G, Degueldre C, Franck G, Luxen A, Lamy M, Moonen G, Maquet P, Laureys S (2004) Auditory processing in severely brain injured patients: differences between the minimally conscious state and the persistent vegetative state. Arch Neurol 61:233-238
15. Cacabelos R, Caamaño J, Gómez MJ, Fernández-Novoa L, Franco-Maside A, Álvarez XA (1996) Therapeutic effects of CDP-Choline in Alzheimer's disease. Cognition, brain mapping, cerebrovascular hemodynamics, and immune factors. Ann NY Acad Sci 777:399-403
16. Chiaretti A, Piastra M, Polidori G, Di Rocco C, Caresta E, Antonelli A, Amendola T, Aloe L (2003) Correlation between neurotrophic factor expression and outcome of children with severe traumatic brain injury. Intensive Care Med 29:1329-1338
17. Coles JP, Steiner LA, Johnston AJ, Fryer TD, Coleman MR, Smieleweski P, Chatfield DA, Aigbirhio F, Williams GB, Boniface S, Rice K, Clark JC, Pickard JD, Menon DK (2004) Does induced hypertension reduce cerebral ischaemia within the traumatized human brain? Brain 127:2479-2490
18. Csuka E, Morganti-Kossmann MC, Lenzlinger PM, Joller H, Trentz O, Kossmann T (1999) IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neuroimmunol 101:211-221
19. Emmerling MR, Morganti-Kossmann MC, Kossmann T, Stahel PF, Watson MD, Evans LM, Mehta PD, Spiegel K, Kuo YM, Roher AE, Raby CA (2000) Traumatic brain injury elevates the Alzheimer's amyloid peptide A beta 42 in human CSF. A possible role for nerve cell injury. Ann NY Acad Sci 903:118-122
20. Faden AI (2002) Neuroprotection and traumatic brain injury: theoretical option or realistic proposition. Curr Opin Neurol 15:707-712
21. Funke M, Fiehler J, Mewes I, Eiselt M, Rother I, Windisch M (1998) Dose-dependent effects of Cerebrolysin on EEG and Short term memory in healthy volunteers during control and hyperventilation induced cerebral ischemia. J Neural Transm Suppl 53:385-398
22. Gschanes A, Windisch M (1998) The influence of Cerebrolysin and E021 on spatial navigation of 24-month-old rats. J Neural Transm 53:313-321
23. Hutter-Paier B, Grygar E, Windisch M (1996) Death of cultured telencephalon neurons induced by glutamate is reduced by the peptide derivative cerebrolysin. J Neural Transm 47:267-273
24. Hutter-Paier B, Steiner E, Windisch M (1998) Cerebrolysin protects isolated neurons from neurodegeneration after brief histotoxic hypoxia. J Neural Transm Suppl 53:351-361
25. Jennett B, Bond M (1975) Assessment of outcome after severe brain damage. A practical scale. Lancet 1:480-484
26. Kane NM, Moss TH, Curry SH, Butler SR (1998) Quantitative electro-encephalographic evaluation of non-fatal and fatal traumatic coma. Electroencephalogr Clin Neurophysiol 106:244-250
27. Kazanis I, Giannakopoulou M, Philippidis H, Stylianopoulou F (2004) Alterations in IGF-I, BDNF and NT-3 levels following experimental brain trauma and the effect of IGF-I administration. Exp Neurol 186:221-234
28. Kersel DA, Marsh NV, Havill JH, Sleigh JW (2001) Neuropsychological functioning during the year following severe traumatic brain injury. Brain Inj 15:283-296
29. Leclercq PD, McKenzie JE, Graham DI, Gentleman SM (2001) Axonal injury is accentuated in the caudal corpus callosum of head-injured patients. J Neurotrauma 18:1-9
30. Lew HL, Lee EH, Pan SS, Date ES (2004) Electrophysiologic abnormalities of auditory and visual information processing in patients with traumatic brain injury. Am J Phys Med Rehabil 83:428-433
31. Lombardi VRM, Windisch M, García M, Cacabelos R (1999) Effects of Cerebrolysin on in vitro primary microglial and astrocyte rat cell cultures. Methods Find Exp Pharmacol 21:331-338
32. Longhi L, Watson DJ, Saatman KE, Thompson HJ, Zhang C, Fujimoto S, Royo N, Castelbuono D, Raghupathi R, Trojanowski JQ, Lee VM, Wolfe JH, Stocchetti N, McIntosh TK (2004) Ex vivo gene therapy using targeted engraftment of NGF-expressing human NT2N neurons attenuates cognitive deficits following traumatic brain injury in mice. J Neurotrauma 21:1723-1736
33. Magnoni S, Stocchetti N, Colombo G, Carling A, Colombo A, Lipton JM, Catania A (2003) Alpha-melanocyte-stimulating hormone is decreased in plasma of patients with acute brain injury. J Neurotrauma 20:251-260
34. Masliah E, Armasolo F, Veinbergs I, Mallory M, Samuel W (1999) Cerebrolysin ameliorates performance deficits, and neuronal damage in apolipoprotein E-deficient mice. Pharmacol Biochem Behav 62:239-245
35. Nagata K, Tagawa K, Hiroi S, Shishido F, Uemura K (1989) Electroencephalographic correlates of blood flow and oxygen metabolism provided by positron emission tomography in patients with cerebral infarction. Electroencephalogr Clin Neurophysiol 72:16-30
36. Overall JE, Schaltenbrand R (1992) The SKT neuropsychological test battery. J Geriatr Psychiatry Neurol 5:220-227
37. Panisset M, Gauthier S, Moessler H, Windisch M (2002) Cerebrolysin in Alzheimer's disease: a ramdomized, double-blind, placebo-controlled trial with a neurotrophic agent. J Neural Transm 109:1089-1104
38. Rapoport M, McCauley S, Levin H, Song J, Feinstein A (2002) The role of injury severity in neurobehavioral outcome 3 months after traumatic brain injury. Neuropsychiatry Neuropsychol Behav Neurol 15:123-132
39. Ray SK, Dixon CE, Banik NL (2002) Molecular mechanisms in the pathogenesis of traumatic brain injury. Histol Histopathol 17:1137-1152
40. Reinprecht I, Gschanes A, Windisch M, Fachbach G (1999) Two peptidergic drugs increase the synaptophysin immunoreactivity in brains of 24-month-old rats. Histochem J 31:395-401
41. Roche RA, Dockree PM, Garavan H, Foxe JJ, Robertson IH, O'Mara SM (2004) EEG alpha power changes reflect response inhibition deficits after traumatic brain injury (TBI) in humans. Neurosci Lett 362:1-5
42. Rockenstein E, Mallory M, Mante M, Alford M, Windisch M, Moessler H, Masliah E (2002) Effects of Cerebrolysin on amyloid-beta deposition in a transgenic model of Alzheimer's disease. J Neural Transm Suppl 62:327-336
43. Ruether E, Husmann R, Kinzler E, Diabl E, Klingler D, Spatt J, Ritter R, Schmidt R, Taneri Z, Winterer W, Koper D, Kasper S, Rainer M, Moessler H (2001) A 28-week, double-blind, placebo-controlled study with Cerebrolysin in patients with mild to moderate Alzheimer's disease. Int Clin Psychopharmacol 16:253-263
44. Ruether E, Álvarez XA, Rainer M, Moessler H (2002) Sustained improvement of cognition and global function in patients with moderately severe Alzheimer's disease: a double-blind, placebo-controlled study with the neurotrophic agent Cerebrolysin. J Neural Transm Suppl 62:265-275
45. Saletu B, Hitzenberger G, Grünberger J, Anderer P, Zyhlarz G, Linzmayer L, Rameis H (1995) Double-blind placebo-controlled, pharmacokinetic and dynamic studies with 2 new formulations of piracetam (infusion and syrup) under hypoxia in man. Int J Clin Pharmacol Ther 33:249-262
46. Satou T, Itoh T, Fujimoto M, Hashimoto S (1994) Neurotrophic-like effects of FPF-1070 on cultured neurons from chick embryonic dorsal root ganglia. Jpn Pharmacol Ther 22:205-212
47. Savola O, Pyhtinen J, Leino TK, Siitonen S, Niemela O, Hillbom M (2004) Effects of head and extracranial injuries on serum protein S100B levels in trauma patients. J Trauma 56:1229-1234
48. Schwab M, Antonow-Schlorke I, Zwiener U, Bauer R (1998) Brain-derived peptides reduce size of cerebral infarction and loss of MAP2 immunoreactivity after focal ischemia in rats. J Neural Transm Suppl 53:299-311
49. Tatebayashi Y, Lee MH, Li L, Iqbal K, Grundke-Iqbal I (2003) The dentate gyrus neurogenesis: a therapeutic target for Alzheimeŕs disease. Acta Neuropathol 105:225-232
50. Teadsdale G, Jennett B (1974) Assessment of coma and impaired consciousness. A practical scale. Lancet 2:81-84
51. Thatcher RW, North DM, Curtin RT, Walker RA, Biver CJ, Gomez JF, Salazar AM (2001) An EEG severity index of traumatic brain injury. J Neuropsychiatry Clin Neurosci 13:77-87
52. Thornton K (2003) The electrophysiological effects of a brain injury on auditory memory functioning. The QEEG correlates of impaired memory. Arch Clin Neuropsychol 18:363-378
53. Valente M, Placidi F, Oliveira AJ, Bigagli A, Morghen I, Proietti R, Gigli GL (2002) Sleep organization pattern as a prognostic marker at the subacute stage of post-traumatic coma. Clin Neurophysiol 113:1798-1805
54. Vespa PM, Boscardin WJ, Hovda DA, McArthur DL, Nuwer MR, Martin NA, Nenov V, Glenn TC, Bergsneider M, Kelly DF, Becker DP (2002) Early and persistent impaired percent alpha variability on continuous electroencephalography monitoring as predictive of poor outcome after traumatic brain injury. J Neurosurg 97:84-92
55. Wallace BE, Wagner AK, Wagner EP, McDeavitt JT (2001) A history and review of quantitative electroencephalography in traumatic brain injury. J Head Trauma Rehabil 16:165-190
56. Winter CD, Pringle AK, Clough GF, Church MK (2004) Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury. Brain 127:315-320